Despite all efforts and success in medical treatment, the incidence of (end-stage) chronic heart failure is increasing. Cardiac transplantation remains the only definite option; however, due to the shortage of donor organs, very few people benefit. Therefore, surgery of end-stage heart failure using conventional techniques has gained new interest after the introduction of the Batista operation. However, a clear surgical identification of the patients to be included in this group is lacking. Left ventricular reduction surgery as well as reduction of the base of the heart using mitral annuloplasty or mitral valve replacement, sparing both papillary muscles, is used in selected patients with satisfying results and good survival. Long-term mechanical support with subsequent surgical remodeling or supporting myoplasty may result in a beneficial alternative to heart transplantation.
Sprache
Verlagsort
Illustrationen
69 s/w Abbildungen
VIII, 134 p. 69 illus.
Dateigröße
ISBN-13
978-3-642-57705-5 (9783642577055)
DOI
10.1007/978-3-642-57705-5
Schweitzer Klassifikation
The heart failure syndrome: new insights - from receptors.- to molecular biology.- End stage heart failure - options for medical treatment and beyond..- Heart transplantation for cardiomyopathy - therapeutic gold standard?.- Cardiac assistance from skeletal muscle: achieving a variable and appropriately transformed graft.- Cardiomyoplasty in chronic heart failure: the Paris Experience.- Biomechanical hearts in aorta-descendens position - operative procedure and volumetry in adult goats.- Geometrical considerations in (reverse) remodeling.- Mitral valve repair for surgical remodeling.- Reduction ventriculoplasty.- Artificial heart: today's facts and future horizons.- Apoptosis in heart failure - reversible?.
